AbstractManagement of rectal cancer has advanced significantly over the last 30 years. As the complexity of treatment increases the question of superspecialization has arisen as a means of concentrating expertise and improving outcome. This article argues that this may have merit, but only for very early and very advanced tumours.
CitationThompson C, Williams JG. Who should be treating rectal cancer in 2013? Br J Hosp Med (Lond). 2013 Jul;74(7):372-6. doi: 10.12968/hmed.2013.74.7.372. PMID: 24159636.
RightsAttribution-NonCommercial-NoDerivs 3.0 United States